Dienogest
- Generic Name
- Dienogest
- Brand Names
- Natazia, Visanne
- Drug Type
- Small Molecule
- Chemical Formula
- C20H25NO2
- CAS Number
- 65928-58-7
- Unique Ingredient Identifier
- 46M3EV8HHE
- Background
Dienogest is an orally-active semisynthetic progestogen which also possesses the properties of 17α-hydroxyprogesterone. It is a derivative of 19-nortestosterone and has antiandrogenic properties. It is primarily used as a contraceptive in combination with ethinylestradiol, or in other combination form pills approved in United States and Europe however it is ...
- Indication
Indicated for use as the treatment of endometriosis alone and as a contraceptive in combination with ethinylestradiol.
- Associated Conditions
- Hypermenorrhea, Pain
- Associated Therapies
- Contraception, Oral Contraceptives
Trial Comparing Preoperative Dienogest Therapy Followed by Surgery vs. Upfront Surgery to Save Ovarian Reserve in Young Women With Ovarian Endometrioma
- Conditions
- Interventions
- First Posted Date
- 2016-04-05
- Last Posted Date
- 2017-10-31
- Lead Sponsor
- Seoul National University Hospital
- Registration Number
- NCT02728245
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam Si, Gyeonggi Do, Korea, Republic of
Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas
- First Posted Date
- 2015-11-06
- Last Posted Date
- 2016-11-22
- Lead Sponsor
- Fundación Santa Fe de Bogota
- Target Recruit Count
- 50
- Registration Number
- NCT02599077
- Locations
- 🇨🇴
Fundación Santa Fe de Bogota, Bogota, Cundinamarca, Colombia
Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women
- Conditions
- Interventions
- First Posted Date
- 2015-05-12
- Last Posted Date
- 2016-03-09
- Lead Sponsor
- University of Cagliari
- Target Recruit Count
- 50
- Registration Number
- NCT02440750
Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome
- First Posted Date
- 2015-04-28
- Last Posted Date
- 2020-12-01
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 210
- Registration Number
- NCT02427334
- Locations
- 🇪🇬
Cairo university hospitals, Cairo, Egypt
Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery
- First Posted Date
- 2015-03-11
- Last Posted Date
- 2015-04-29
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 144
- Registration Number
- NCT02385448
- Locations
- 🇭🇰
Queen Mary Hospital, Hong Kong, Hong Kong
Synthetic vs Natural Estrogen in Combined Oral Contraception
- Conditions
- Interventions
- First Posted Date
- 2015-02-02
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 59
- Registration Number
- NCT02352090
- Locations
- 🇫🇮
Helsinki University Central Hospital, Kätilöopisto Maternity Hospital, Helsinki, Finland
🇫🇮Oulu University Hospital, Department of Gynecology and Obstetrics, Oulu, Finland
Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin
- Conditions
- Interventions
- First Posted Date
- 2012-11-30
- Last Posted Date
- 2020-08-13
- Lead Sponsor
- University of Sao Paulo
- Target Recruit Count
- 14
- Registration Number
- NCT01738724
Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis
- Conditions
- Interventions
- First Posted Date
- 2012-10-02
- Last Posted Date
- 2016-02-18
- Lead Sponsor
- Bayer
- Target Recruit Count
- 312
- Registration Number
- NCT01697111
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.